In a CRC SW837 cell line-derived xenograft with acquired resistance to adagrasib, Thatikonda et al. showed that addition of BI-3406 to adagrasib overcame induced resistance to KRAS inhibitor monotherapy [129]. The gene discussed is KRAS; the disease is colorectal carcinoma.